Selected research
Industry Growth & Trends
Global Cognitive Behavioral Therapy for Insomnia Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Cognitive Behavioral Therapy for Insomnia market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Cognitive Behavioral Therapy for Insomnia is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Cognitive Behavioral Therapy for Insomnia is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cognitive Behavioral Therapy for Insomnia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Cognitive Behavioral Therapy for Insomnia market include MINERVA NEUROSCIENCES INC, CURRAX PHARMACEUTICALS LLC, Pfizer Inc., Sanofi, zydus cadila, Vanda Pharmaceuticals Inc., EISAI,, merck kgaa and darmstadt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Cognitive Behavioral Therapy for Insomnia market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cognitive Behavioral Therapy for Insomnia market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cognitive Behavioral Therapy for Insomnia market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cognitive Behavioral Therapy for Insomnia.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Cognitive Behavioral Therapy for Insomnia market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cognitive Behavioral Therapy for Insomnia Market by Company
MINERVA NEUROSCIENCES INC
CURRAX PHARMACEUTICALS LLC
Pfizer Inc.
Sanofi
zydus cadila
Vanda Pharmaceuticals Inc.
EISAI,
merck kgaa
darmstadt
germany
VIATRIS INC
Takeda Pharmaceutical Company
Cognitive Behavioral Therapy for Insomnia Segment by Type
Non Pharmacological Therapy
Pharmacological Therapy
Cognitive Behavioral Therapy for Insomnia Segment by Application
Mental Health Services
Sleep Clinics
Pharmaceutical Industry
Sleep-related Devices and Technology
Cognitive Behavioral Therapy for Insomnia Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cognitive Behavioral Therapy for Insomnia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cognitive Behavioral Therapy for Insomnia and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cognitive Behavioral Therapy for Insomnia.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Cognitive Behavioral Therapy for Insomnia companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Non Pharmacological Therapy
- Pharmacological Therapy
Applications
- Mental Health Services
- Sleep Clinics
- Pharmaceutical Industry
- Sleep-related Devices and Technology
Companies covered
- MINERVA NEUROSCIENCES INC
- CURRAX PHARMACEUTICALS LLC
- Pfizer Inc.
- Sanofi
- zydus cadila
- Vanda Pharmaceuticals Inc.
- EISAI,
- merck kgaa
- darmstadt
- germany
- VIATRIS INC
- Takeda Pharmaceutical Company
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Cognitive Behavioral Therapy for Insomnia Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Cognitive Behavioral Therapy for Insomnia Market Size by Region (2021-2032)
- 1.4.1 Global Cognitive Behavioral Therapy for Insomnia Market Size by Region (2021-2026)
- 1.4.2 Global Cognitive Behavioral Therapy for Insomnia Market Size by Region (2027-2032)
- 1.5 Key Regions Cognitive Behavioral Therapy for Insomnia Market Size (2021-2032)
- 1.5.1 North America Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate (2021-2032)
- 1.5.4 South America Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate (2021-2032)
2 Cognitive Behavioral Therapy for Insomnia Market by Type
- 2.1 Type Introduction
- 2.1.1 Non Pharmacological Therapy
- 2.1.2 Pharmacological Therapy
- 2.2 Global Cognitive Behavioral Therapy for Insomnia Market Size by Type
- 2.2.1 Global Cognitive Behavioral Therapy for Insomnia Market Size Overview by Type (2021-2032)
- 2.2.2 Global Cognitive Behavioral Therapy for Insomnia Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Cognitive Behavioral Therapy for Insomnia Market Size Forecasted by Type (2027-2032)
- 2.3 Global Cognitive Behavioral Therapy for Insomnia Market Size by Regions
- 2.3.1 North America Cognitive Behavioral Therapy for Insomnia Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Cognitive Behavioral Therapy for Insomnia Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Cognitive Behavioral Therapy for Insomnia Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Cognitive Behavioral Therapy for Insomnia Market Size Breakdown by Type (2021-2026)
3 Cognitive Behavioral Therapy for Insomnia Market by Application
- 3.1 Type Introduction
- 3.1.1 Mental Health Services
- 3.1.2 Sleep Clinics
- 3.1.3 Pharmaceutical Industry
- 3.1.4 Sleep-related Devices and Technology
- 3.2 Global Cognitive Behavioral Therapy for Insomnia Market Size by Application
- 3.2.1 Global Cognitive Behavioral Therapy for Insomnia Market Size Overview by Application (2021-2032)
- 3.2.2 Global Cognitive Behavioral Therapy for Insomnia Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Cognitive Behavioral Therapy for Insomnia Market Size Forecasted by Application (2027-2032)
- 3.3 Global Cognitive Behavioral Therapy for Insomnia Market Size by Regions
- 3.3.1 North America Cognitive Behavioral Therapy for Insomnia Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Cognitive Behavioral Therapy for Insomnia Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Cognitive Behavioral Therapy for Insomnia Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Cognitive Behavioral Therapy for Insomnia Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Cognitive Behavioral Therapy for Insomnia Industry Trends
- 4.2 Cognitive Behavioral Therapy for Insomnia Industry Drivers
- 4.3 Cognitive Behavioral Therapy for Insomnia Industry Opportunities and Challenges
- 4.4 Cognitive Behavioral Therapy for Insomnia Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Cognitive Behavioral Therapy for Insomnia Revenue (2021-2026)
- 5.2 Global Cognitive Behavioral Therapy for Insomnia Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Cognitive Behavioral Therapy for Insomnia Key Company Headquarters & Area Served
- 5.4 Global Cognitive Behavioral Therapy for Insomnia Company, Product Type & Application
- 5.5 Global Cognitive Behavioral Therapy for Insomnia Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Cognitive Behavioral Therapy for Insomnia Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Cognitive Behavioral Therapy for Insomnia Players Market Share by Revenue in 2025
- 5.6.3 2025 Cognitive Behavioral Therapy for Insomnia Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 MINERVA NEUROSCIENCES INC
- 6.1.1 MINERVA NEUROSCIENCES INC Company Information
- 6.1.2 MINERVA NEUROSCIENCES INC Business Overview
- 6.1.3 MINERVA NEUROSCIENCES INC Cognitive Behavioral Therapy for Insomnia Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 MINERVA NEUROSCIENCES INC Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 6.1.5 MINERVA NEUROSCIENCES INC Recent Developments
- 6.2 CURRAX PHARMACEUTICALS LLC
- 6.2.1 CURRAX PHARMACEUTICALS LLC Company Information
- 6.2.2 CURRAX PHARMACEUTICALS LLC Business Overview
- 6.2.3 CURRAX PHARMACEUTICALS LLC Cognitive Behavioral Therapy for Insomnia Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 CURRAX PHARMACEUTICALS LLC Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 6.2.5 CURRAX PHARMACEUTICALS LLC Recent Developments
- 6.3 Pfizer Inc.
- 6.3.1 Pfizer Inc. Company Information
- 6.3.2 Pfizer Inc. Business Overview
- 6.3.3 Pfizer Inc. Cognitive Behavioral Therapy for Insomnia Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Pfizer Inc. Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 6.3.5 Pfizer Inc. Recent Developments
- 6.4 Sanofi
- 6.4.1 Sanofi Company Information
- 6.4.2 Sanofi Business Overview
- 6.4.3 Sanofi Cognitive Behavioral Therapy for Insomnia Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Sanofi Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 6.4.5 Sanofi Recent Developments
- 6.5 zydus cadila
- 6.5.1 zydus cadila Company Information
- 6.5.2 zydus cadila Business Overview
- 6.5.3 zydus cadila Cognitive Behavioral Therapy for Insomnia Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 zydus cadila Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 6.5.5 zydus cadila Recent Developments
- 6.6 Vanda Pharmaceuticals Inc.
- 6.6.1 Vanda Pharmaceuticals Inc. Company Information
- 6.6.2 Vanda Pharmaceuticals Inc. Business Overview
- 6.6.3 Vanda Pharmaceuticals Inc. Cognitive Behavioral Therapy for Insomnia Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Vanda Pharmaceuticals Inc. Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 6.6.5 Vanda Pharmaceuticals Inc. Recent Developments
- 6.7 EISAI,
- 6.7.1 EISAI, Company Information
- 6.7.2 EISAI, Business Overview
- 6.7.3 EISAI, Cognitive Behavioral Therapy for Insomnia Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 EISAI, Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 6.7.5 EISAI, Recent Developments
- 6.8 merck kgaa
- 6.8.1 merck kgaa Company Information
- 6.8.2 merck kgaa Business Overview
- 6.8.3 merck kgaa Cognitive Behavioral Therapy for Insomnia Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 merck kgaa Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 6.8.5 merck kgaa Recent Developments
- 6.9 darmstadt
- 6.9.1 darmstadt Company Information
- 6.9.2 darmstadt Business Overview
- 6.9.3 darmstadt Cognitive Behavioral Therapy for Insomnia Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 darmstadt Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 6.9.5 darmstadt Recent Developments
- 6.10 germany
- 6.10.1 germany Company Information
- 6.10.2 germany Business Overview
- 6.10.3 germany Cognitive Behavioral Therapy for Insomnia Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 germany Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 6.10.5 germany Recent Developments
- 6.11 VIATRIS INC
- 6.11.1 VIATRIS INC Company Information
- 6.11.2 VIATRIS INC Business Overview
- 6.11.3 VIATRIS INC Cognitive Behavioral Therapy for Insomnia Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 VIATRIS INC Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 6.11.5 VIATRIS INC Recent Developments
- 6.12 Takeda Pharmaceutical Company
- 6.12.1 Takeda Pharmaceutical Company Company Information
- 6.12.2 Takeda Pharmaceutical Company Business Overview
- 6.12.3 Takeda Pharmaceutical Company Cognitive Behavioral Therapy for Insomnia Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Takeda Pharmaceutical Company Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 6.12.5 Takeda Pharmaceutical Company Recent Developments
7 North America
- 7.1 North America Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Cognitive Behavioral Therapy for Insomnia Market Size by Country (2021-2026)
- 7.3 North America Cognitive Behavioral Therapy for Insomnia Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Cognitive Behavioral Therapy for Insomnia Market Size by Country (2021-2026)
- 8.3 Europe Cognitive Behavioral Therapy for Insomnia Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Cognitive Behavioral Therapy for Insomnia Market Size by Country (2021-2026)
- 10.3 South America Cognitive Behavioral Therapy for Insomnia Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Cognitive Behavioral Therapy for Insomnia Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Cognitive Behavioral Therapy for Insomnia Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst